Akoya Biosciences, Inc.
AKYA · NASDAQ
3/31/2025 | 12/31/2024 | 9/30/2024 | 6/30/2024 | |
|---|---|---|---|---|
| Market Cap | $69,034 | $113,493 | $134,649 | $109,218 |
| - Cash | $20,357 | $11,779 | $12,557 | $8,923 |
| + Debt | $83,723 | $84,146 | $84,919 | $84,698 |
| Enterprise Value | $132,400 | $185,860 | $207,011 | $184,993 |
| Revenue | $16,639 | $21,344 | $18,814 | $23,164 |
| % Growth | -22% | 13.4% | -18.8% | – |
| Gross Profit | $9,871 | $14,389 | $11,724 | $13,386 |
| % Margin | 59.3% | 67.4% | 62.3% | 57.8% |
| EBITDA | -$11,314 | -$3,769 | -$6,039 | -$8,570 |
| % Margin | -68% | -17.7% | -32.1% | -37% |
| Net Income | -$15,652 | -$8,199 | -$10,533 | -$13,149 |
| % Margin | -94.1% | -38.4% | -56% | -56.8% |
| EPS Diluted | -0.32 | -0.17 | -0.21 | -0.27 |
| % Growth | -88.2% | 19% | 22.2% | – |
| Operating Cash Flow | -$7,214 | -$2,982 | -$9,256 | -$11,041 |
| Capital Expenditures | -$204 | -$1,042 | -$434 | -$170 |
| Free Cash Flow | -$7,418 | -$4,024 | -$9,690 | -$11,211 |